Programming Photodynamic Therapy with Glycopolymeric Photosensitizers: From Carbohydrate Recognition to Light-Activated Nanomedicine

Conspectus Glycopolymers are synthetic macromolecules that display multiple carbohydrate motifs and mimic the multivalent presentation of glycans in biological systems. Advances in controlled polymerization now allow chain length, sugar density, sequence, composition, and topology to be tuned with increasing precision. As a result, glycopolymers have progressed from models of carbohydrate-lectin recognition to materials for receptor- and transporter-mediated targeting, drug delivery, and precision therapy. Studies of fructose-containing micelles showed that cellular interactions depend not only on sugar identity or total sugar content but also on chain length, local density, spatial arrangement, and carbohydrate accessibility. These principles were then applied to drug delivery, where polymer composition and self-assembly improved the aqueous encapsulation of poorly soluble drugs, regulated nanoparticle size, and promoted intracellular distribution. Glycopolymers therefore became functional materials that control both biological recognition and the organization of therapeutic molecules. Glycopolymeric photosensitizers extend this concept to photodynamic therapy (PDT), in which photosensitizers convert light into localized photochemical effects. Porphyrins are attractive because of their optical properties and ability to generate reactive oxygen species (ROS), but their use is limited by poor aqueous dispersibility, aggregation, nonspecific uptake, altered photochemical activity, and inadequate intracellular localization. Photosensitizer delivery is therefore not simply a solubilization problem; it requires coordinated control over molecular organization, biological targeting, and intracellular transport. Glycopolymers can address these challenges through physical loading or covalent incorporation. Physical loading is simple and adaptable but may provide limited control over loading and retention, whereas covalent attachment allows more precise regulation of photosensitizer content and placement. To combine photosensitizer organization with carbohydrate-mediated targeting, we developed several covalent glycopolymeric photosensitizers. Porphyrin-containing random and block glycopolymers revealed how polymer sequence influences aggregation, intracellular ROS generation, and photocytotoxicity. Porphyrin-core star glycopolymers further showed that arm length, carbohydrate identity, and corona composition affect recognition, uptake, and PDT response, while related systems enabled combined therapeutic functions. Their synthesis also evolved from conventional ATRP, which requires added catalytic systems and does not directly link photosensitizer function with polymer formation, toward light-mediated polymerization. In photoATRP, we developed a triple-function zinc porphyrin that serves as initiator, photocatalytic component, and photosensitizer. A complementary self-photocatalyzed PET-RAFT strategy used a polymerizable porphyrin that participates in polymerization and becomes covalently embedded in the glycopolymer. This Account traces the evolution of glycopolymers from multivalent recognition to targeted drug delivery and glycopolymeric photosensitizers. Here, “programming” refers to the deliberate design of molecular architecture, the control of nanoscale assembly, and the integration of polymer synthesis with photosensitizer function. It emphasizes how carbohydrate presentation, polymer architecture, self-assembly, and photochemistry jointly govern recognition, intracellular transport, and therapeutic performance and how integrating polymer synthesis, targeting, and photosensitization may guide next-generation precision phototherapeutics.